California Public Employees Retirement System
DNLI icon

California Public Employees Retirement System’s Denali Therapeutics DNLI Stock Holding History

California Public Employees Retirement System’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-176,131
Closed -$3.78M – 1177
2023
Q4 		$3.78M Hold
176,131
– – ﹤0.01% 1131
2023
Q3 		$3.63M Hold
176,131
– – ﹤0.01% 1126
2023
Q2 		$5.2M Hold
176,131
– – ﹤0.01% 1067
2023
Q1 		$4.06M Sell
176,131
-17,430
-9% -$480K ﹤0.01% 1121
2022
Q4 		$5.38M Sell
193,561
-6,294
-3% -$187K ﹤0.01% 1092
2022
Q3 		$6.13M Sell
199,855
-2,322
-1% -$75.5K 0.01% 1057
2022
Q2 		$5.95M Hold
202,177
– – 0.01% 1034
2022
Q1 		$6.5M Hold
202,177
– – 0.01% 1086
2021
Q4 		$9.02M Buy
202,177
+803
+0.4% +$38K 0.01% 1023
2021
Q3 		$10.2M Buy
201,374
+2,713
+1% +$153K 0.01% 992
2021
Q2 		$15.6M Buy
198,661
+35,329
+22% +$2.19M 0.01% 789
2021
Q1 		$9.33M Buy
163,332
+9,434
+6% +$632K 0.01% 1120
2020
Q4 		$12.9M Buy
153,898
+11,126
+8% +$673K 0.01% 865
2020
Q3 		$5.12M Buy
142,772
+3,600
+3% +$108K ﹤0.01% 1220
2020
Q2 		$3.37M Buy
139,172
+30,499
+28% +$717K ﹤0.01% 1462
2020
Q1 		$1.9M Buy
108,673
+100
+0.1% +$2.09K ﹤0.01% 1630
2019
Q4 		$1.89M Buy
108,573
+19,900
+22% +$331K ﹤0.01% 2056
2019
Q3 		$1.36M Buy
88,673
+73,291
+476% +$1.4M ﹤0.01% 2122
2019
Q2 		$319K Buy
15,382
+5,800
+61% +$130K ﹤0.01% 2716
2019
Q1 		$222K Buy
+9,582
New +$200K ﹤0.01% 2875

Other funds holding DNLI

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $53.5M AUM 80.67% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

California Public Employees Retirement System's DNLI Position: Q1 2024 in Review

California Public Employees Retirement System sold out of Denali Therapeutics (DNLI) in Q1 2024, closing a stake of 176,131 shares — an estimated $3.78M sold.

California Public Employees Retirement System first reported a position in DNLI in Q1 2019 and held it in 20 quarters. The position peaked at $15.6M in Q2 2021. 210 funds tracked by Wall St. Rank hold DNLI as of Q1 2024.

  • California Public Employees Retirement System reported no remaining Denali Therapeutics position as of Q1 2024 after selling out during the quarter.
  • California Public Employees Retirement System sold 176,131 Denali Therapeutics shares in Q1 2024, an estimated $3.78M.
  • California Public Employees Retirement System first reported a position in Denali Therapeutics in Q1 2019 and held it in 20 quarters.
  • California Public Employees Retirement System's Denali Therapeutics position peaked at $15.6M in Q2 2021.
  • 210 funds tracked by Wall St. Rank held Denali Therapeutics as of Q1 2024.

Based on California Public Employees Retirement System's 13F filing for Q1 2024, filed 30 Apr 2024.